Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.67
Jul. 09, 2026 16:00:00- Change 0.0218 (3.35281%)
- Volume 27,042
- Today's Open 0.6466
- Previous Close 0.6502
- Today's High 0.6789
- Today's Low 0.6466
- 52 Week High 1.595
- 52 Week Low 0.281